These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21839007)

  • 1. Criteria for hepatitis B virus screening and validation of blood components in Italy: the position of the SIMTI HBV working group.
    Velati C; Fomiatti L; Baruffi L; Piccinini V; Prati D; Reina A; Lobbiani A; Zanetti A; Romanò L
    Blood Transfus; 2011 Oct; 9(4):455-61. PubMed ID: 21839007
    [No Abstract]   [Full Text] [Related]  

  • 2. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
    van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
    Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
    Muselmani W; Habbal W; Monem F
    Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient occult hepatitis B virus infection in a blood donor with high viremia.
    Bremer CM; Saniewski M; Wend UC; Torres P; Lelie N; Gerlich WH; Glebe D
    Transfusion; 2009 Aug; 49(8):1621-9. PubMed ID: 19413737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of supplemental anti-HBc testing of donors showing non-discriminating reactive results in multiplex nucleic acid testing.
    Kang JW; Seo JH; Youn KW; Seo YI; Huh K; Choi GR; Min HK; Oh DJ; Jo HJ; Kim JN
    Vox Sang; 2017 Oct; 112(7):622-627. PubMed ID: 28891069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.
    van de Laar TJ; Marijt-van der Kreek T; Molenaar-de Backer MW; Hogema BM; Zaaijer HL
    Transfusion; 2015 Jun; 55(6):1206-13. PubMed ID: 25494685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult and active hepatitis B virus detection in donated blood in São Paulo, Brazil.
    Nishiya AS; Levi JE; de Almeida-Neto C; Witkin SS; Ferreira SC; Bassit L; Sabino EC; Di-Lorenzo-Oliveira C; Salles NA; Coutinho AS; Bellesa MA; Rocha V; Mendrone-Jr A
    Transfusion; 2021 May; 61(5):1495-1504. PubMed ID: 33687074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A strategical re-thinking on National Blood Donor Pool: Anti-HBc positivity related re-entry mechanisms.
    Yilmaz S; Unlu A; Cetinkaya RA; Yapar M; Avci IY; Yilmaz S; Eyigun CP
    Transfus Apher Sci; 2016 Apr; 54(2):271-5. PubMed ID: 26928919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serological Profiles of Hepatitis-B HBcAb-Positive Blood donors ].
    Beltrán-Durán M; Berrío-Pérez M; Bermúdez-Forero MI; Cortés-Buelvas AD; Molina-Guevara GC; Camacho-Rodríguez BA; Forero-Matiz SP
    Rev Salud Publica (Bogota); 2014; 16(6):847-58. PubMed ID: 26120855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P; Margaritis AR; Seed CR; Yang H;
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult hepatitis B infection and transfusion-transmission risk.
    Candotti D; Boizeau L; Laperche S
    Transfus Clin Biol; 2017 Sep; 24(3):189-195. PubMed ID: 28673499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission.
    El-Zayadi AR; Ibrahim EH; Badran HM; Saeid A; Moneib NA; Shemis MA; Abdel-Sattar RM; Ahmady AM; El-Nakeeb A
    Transfus Med; 2008 Feb; 18(1):55-61. PubMed ID: 18279193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.
    Stolz M; Tinguely C; Fontana S; Niederhauser C
    Transfusion; 2014 Nov; 54(11):2961-7. PubMed ID: 24805974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors.
    Seo DH; Whang DH; Song EY; Kim HS; Park Q
    Transfusion; 2011 Aug; 51(8):1840-6. PubMed ID: 21332731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
    Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.